title: ACCF/AHA Clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association.
authors.forename: David R
authors.initials: DR
authors.lastname: Holmes
authors.forename: Gregory J
authors.initials: GJ
authors.lastname: Dehmer
authors.forename: Sanjay
authors.initials: S
authors.lastname: Kaul
authors.forename: Dana
authors.initials: D
authors.lastname: Leifer
authors.forename: Patrick T
authors.initials: PT
authors.lastname: O'Gara
authors.forename: C Michael
authors.initials: CM
authors.lastname: Stein
mesh_terms: D000572:American Heart Association; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000453:epidemiology / Q000235:genetics; D000077144:Clopidogrel; D000075202:Contraindications; D065731:Cytochrome P-450 CYP2C19; D004348:Drug Labeling; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D014481:United States
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19; D013988:Ticlopidine